Arca
Skip to content
Tools
Tools

TSPO: Translocator protein

Can bind protoporphyrin IX and may play a role in the transport of porphyrins and heme.

  • Drugs that act on it: 3
  • Approved: 1
  • In phases 1 to 3: 2
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on TSPO, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved1

  • Alpidem

Phase 30

    Phase 22

    • Emapunil
    • ONO-2952

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      AlpidemWithdrawnApproved—Small moleculePartial agonistTranslocator protein partial agonist0
      EmapunilPhase 2Novartis PharmaceuticalsSmall moleculeAgonistTranslocator protein agonist1
      ONO-2952Phase 2Ono PharmaceuticalSmall moleculeAntagonistTranslocator protein antagonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 1 in all, from ClinicalTrials.gov.
      TrialDrugPhaseStatusLead sponsorFirst posted
      Role of a Mitochondrial Receptor in Blood Sugar RegulationEmapunilPhase 2RecruitingImperial College LondonJul 2, 2026

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      • Neurodegenerative disease0.46
      • Alzheimer disease0.40
      • Parkinson disease0.39
      • Lysosomal storage disease0.36
      • Autoimmune disorder of central nervous system0.25
      • Neoplasm0.12
      • Prostate carcinoma0.12

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL5742, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P30536, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.